Koesten, Hirschmann & Crabtree, Inc. Johnson & Johnson Transaction History
Koesten, Hirschmann & Crabtree, Inc.
- $192 Million
- Q2 2025
A detailed history of Koesten, Hirschmann & Crabtree, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Koesten, Hirschmann & Crabtree, Inc. holds 107 shares of JNJ stock, worth $20,184. This represents 0.01% of its overall portfolio holdings.
Number of Shares
107
Previous 60
78.33%
Holding current value
$20,184
Previous $9,000
77.78%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding JNJ
# of Institutions
4,657Shares Held
1.77BCall Options Held
18.4MPut Options Held
15.2M-
Vanguard Group Inc Valley Forge, PA237MShares$44.7 Billion0.61% of portfolio
-
Black Rock Inc. New York, NY198MShares$37.4 Billion0.67% of portfolio
-
State Street Corp Boston, MA133MShares$25.1 Billion0.78% of portfolio
-
Geode Capital Management, LLC Boston, MA60.6MShares$11.4 Billion0.67% of portfolio
-
Jpmorgan Chase & CO New York, NY54.1MShares$10.2 Billion0.7% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $493B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...